These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9814690)

  • 1. Antiphospholipid antibodies and myocardial infarction.
    Vaarala O
    Lupus; 1998; 7 Suppl 2():S132-4. PubMed ID: 9814690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies and atherosclerosis.
    Matsuura E; Kobayashi K; Yasuda T; Koike T
    Lupus; 1998; 7 Suppl 2():S135-9. PubMed ID: 9814691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to oxidised LDL.
    Vaarala O
    Lupus; 2000; 9(3):202-5. PubMed ID: 10805488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
    Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):204-9. PubMed ID: 10634819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
    Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
    Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
    Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
    Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein.
    Vaarala O; Puurunen M; Lukka M; Alfthan G; Leirisalo-Repo M; Aho K; Palosuo T
    Clin Exp Immunol; 1996 May; 104(2):269-74. PubMed ID: 8625519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.
    Petri M
    Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
    Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
    Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
    Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus.
    Vaarala O; Alfthan G; Jauhiainen M; Leirisalo-Repo M; Aho K; Palosuo T
    Lancet; 1993 Apr; 341(8850):923-5. PubMed ID: 8096266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies.
    Schlame M; Haller I; Sammaritano LR; Blanck TJ
    Thromb Haemost; 2001 Dec; 86(6):1475-82. PubMed ID: 11776316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome.
    Cuadrado MJ; Tinahones F; Camps MT; de Ramon E; Gómez-Zumaquero JM; Mujic F; Khamashta MA; Hughes GR
    QJM; 1998 Sep; 91(9):619-26. PubMed ID: 10024916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?
    Sherer Y; Shoenfeld Y
    Immunobiology; 2003; 207(1):13-6. PubMed ID: 12638897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
    Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies and atherosclerosis.
    Vaarala O
    Lupus; 1996 Oct; 5(5):442-7. PubMed ID: 8902778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.